Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention GSK, the most common co-covered peer. We currently track 1 Biotech story that mention Meningitis Now, all published on March 18, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Meningitis Now
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention GSK, the most common co-covered peer. We currently track 1 Biotech story that mention Meningitis Now, all published on March 18, 2026. Each carries 2 original sources on average.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Meningitis Now. Shared-story counts are live from our verified record — not editorial picks.
Public health authorities have initiated an emergency vaccination campaign for students following a series of fatal meningitis cases in the UK. The drive aims to contain the spread of invasive meningococcal disease within high-risk educational environments through the rapid deployment of MenACWY and MenB vaccines.